Todd Verdoorn

Todd Verdoorn is a declared insider of DiaMedica Therapeutics Inc., with filings sourced from SEC (Form 4). We count 6 filings; the first trade dates from 9 May 2016 and the latest from 11 December 2018.

No open-market sale appears; the market trades are 3 purchases worth €7,825. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2018 to date brings 2 purchases and no sales.

A typical purchase (the median) is worth €2,957. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The record was last updated on 11 December 2018 with a transaction in DiaMedica Therapeutics Inc. The last insider purchase was made public on 2 August 2018, 3,022 days ago. Typically, a trade is published a median of 15 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.